№ files_lp_4_process_1_42301
File format: docx
Character count: 5235
File size: 18 KB
Compilation of official online resources providing clinical guidance, outbreak data, vaccination information, and public health recommendations on measles for professionals and the general public.
Year:
2026
Region:
United States, Montana and surrounding states
Topic:
Measles prevention, control, and vaccination
Document Type:
Resource compilation
Target Audience:
Health care and public health professionals, general public
Content Includes:
Clinical overviews, outbreak data, infection control guidelines, post-exposure prophylaxis, vaccination information, public information materials
Format:
Online documents, dashboards, flyers, checklists, PDFs
Related Period:
Current epidemiological data up to 2026
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Topic:
Measles testing, PCR and serology
Document Type:
Procedure
Organization / Institution:
Public Health Ontario
Target Audience:
Healthcare professionals, laboratory staff
Year:
2024
Region/City:
Healthcare settings
Theme:
Measles risk assessment, infection control
Document Type:
Risk assessment guidelines
Organization/Institution:
Healthcare Safety Executive (HSE)
Author:
Not specified
Target Audience:
Healthcare organizations, employers, practitioners
Period of validity:
Ongoing, requires regular review
Approval Date:
19 March 2024
Date of Changes:
Not specified
Year:
1968
Region / City:
United Kingdom
Topic:
Vaccination, Measles, Immunology
Document Type:
Educational Text
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Students, Health professionals
Effective Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023
Region / City:
United States
Theme:
Measles Awareness
Document Type:
Public Service Announcement
Organization:
Kansas Department of Health and Environment (KDH&E)
Target Audience:
General public, especially those unvaccinated or at risk
Period of Action:
Ongoing
Approval Date:
N/A
Date of Changes:
N/A
Year:
2026
Region / city:
England
Topic:
Vaccination
Document type:
Patient Group Direction (PGD)
Organization:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Dr Vanessa Saliba, David Green
Target audience:
Healthcare practitioners
Validity period:
20 January 2026 – 30 November 2028
Approval date:
20 January 2026
Review date:
31 May 2028
Expiry date:
30 November 2028
Note:
Change history
Year:
2025
Region / city:
England
Topic:
Vaccination
Document type:
Patient Group Direction (PGD)
Issuing organization:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Dr. Vanessa Saliba, David Green
Target audience:
Healthcare practitioners authorized to administer vaccines
Valid from:
1 January 2026
Review date:
31 May 2028
Expiry date:
30 November 2028
Version:
7.0
Date of approval:
19 December 2025
Amendments:
Last amendment on 19 December 2025
Year:
Not specified
Region / city:
Not specified
Theme:
Measles detection
Document type:
Protocol
Organization / institution:
EuroImmun
Author:
Not specified
Target audience:
Laboratory personnel, medical researchers
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Note:
Date
Topic:
Healthcare exposure, measles
Document Type:
Notification letter
Organization / Institution:
[Healthcare Facility]
Author:
[Health Officer Name]
Target Audience:
Patients, healthcare workers, pregnant women, individuals with compromised immunity
Context:
A template letter informing individuals of potential exposure to measles in a healthcare setting, providing instructions to assess their immunity and take necessary precautions.
Year:
2023
Region / City:
Spokane
Subject:
Measles surveillance
Document type:
Health assessment form
Organization:
Spokane Regional Health District
Author:
Unknown
Target audience:
Health care providers
Period of validity:
N/A
Approval date:
N/A
Modification date:
N/A
Year:
N/A
Region / City:
N/A
Topic:
Immunization Requirements for Staff in Childcare Programs
Document Type:
Staff Documentation / Worksheet
Organization / Institution:
EEC-regulated childcare programs
Author:
N/A
Target Audience:
Childcare staff responsible for maintaining immunization records
Period of Validity:
N/A
Approval Date:
N/A
Date of Revisions:
N/A
Year:
20XX
Region / city:
London
Topic:
Measles, Mumps, Rubella
Document type:
Request form
Organ / institution:
UK Health Security Agency (UKHSA)
Author:
Health Protection Team
Target audience:
Parents/guardians of individuals suspected of having measles, mumps, or rubella
Action period:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Context:
Request form for submitting oral fluid samples to confirm the presence of Measles, Mumps, or Rubella in individuals, with instructions for completing and returning the form and sample.
Year:
2025
Region / City:
United States
Topic:
Immunization, Measles
Document Type:
Resolution
Organization / Institution:
World Health Assembly
Target Audience:
Governments, Public Health Officials
Action Period:
2025–2030
Approval Date:
2025
Date of Amendments:
N/A
Date:
[ENTER DATE]
Issuing Body:
[ENTER TOWN NAME] Health Department / Board of Health
Region:
[ENTER TOWN NAME], Massachusetts, United States
Country:
United States
Type of Document:
Public Service Announcement (PSA)
Subject:
Measles outbreaks and vaccination guidance
Related Institutions:
Massachusetts Department of Public Health – Epidemiology Division; Centers for Disease Control and Prevention
Audience:
Residents of [ENTER TOWN NAME]; families; schools; childcare providers; local organizations
Public Health Focus:
Measles transmission, vaccination coverage, outbreak data
Epidemiological Context:
Ongoing measles outbreaks in multiple U.S. states, including New York, Rhode Island, and Vermont
Prevention Measures:
MMR vaccination, medical consultation, monitoring of symptoms, pre-travel vaccination
Vaccination Effectiveness:
93% protection after one dose; 97% protection after two doses
Year:
2024
Region / City:
Oregon, Marion, Clackamas, Multnomah Counties
Topic:
Health and Safety, Measles Outbreak
Document Type:
Public Health Advisory
Organization:
Oregon Health Authority (OHA)
Author:
Oregon Health Authority
Target Audience:
School Staff, Parents, General Public
Period of Action:
August 2024 - Ongoing
Approval Date:
2024-08-25
Date of Updates:
Ongoing
Contact Information:
[Insert LPHA contact]
Website:
https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/VACCINESIMMUNIZATION/GETTINGIMMUNIZED/Pages/ImmRecords.aspx
Context:
A public health advisory providing guidelines for school staff and the community on how to prevent the spread of measles and what actions to take if an outbreak occurs in Oregon.
Document type:
Sample communication letter
Topic:
Measles outbreak information and vaccination guidance
Disease:
Measles
Institutions referenced:
Centers for Disease Control and Prevention (CDC); Department of Health Services (DHS)
Geographic reference:
United States; Wisconsin
Audience:
School staff and employees
Sector:
Education and public health
Purpose:
Inform staff about measles cases and vaccination requirements
Vaccine referenced:
Measles, Mumps, Rubella (MMR) vaccine
Related system:
Wisconsin Immunization Registry (WIR)
Responsible department mentioned:
Human Resources
Legal references:
FERPA; employment law confidentiality provisions
Distribution context:
School district internal communication
Year:
2024
Region / City:
Arlington, VA
Topic:
High-Leverage Practices for Students with Disabilities
Document Type:
Self-assessment tool
Organization / Institution:
Council for Exceptional Children, CEEDAR Center
Authors:
T. C. Aceves, M. J. Kennedy, A. I. Hashey, T. L. Kaczorowski, D. M. DiCesare, J. McLeskey
Target Audience:
Educators, special education professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Last Update:
February 2024
Year:
2023
Region / City:
Oklahoma, USA
Topic:
Organizational structure and membership
Document type:
Bylaws
Organization / Institution:
Meeting Professionals International (MPI)
Author:
MPI Oklahoma Chapter Board of Directors
Target Audience:
MPI members, Chapter members
Effective period:
From adoption date onward
Approval date:
April 2023
Amendment date:
April 2023
Year:
2023
Region / City:
Missouri
Topic:
Mental Health, Developmental Disabilities, Employment Services
Document Type:
Application Form
Agency / Institution:
Missouri Department of Mental Health, Division of Developmental Disabilities
Author:
Missouri Department of Mental Health
Target Audience:
Individuals and organizations applying for provider contracts
Validity Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
2025
Region / city:
[insert local health board name]
Theme:
Vaccination
Document type:
Patient Group Direction (PGD)
Authorising organisation:
NHS Wales
Target audience:
Healthcare professionals (Registered)
Period of validity:
01 September 2025 - 31 March 2026
Approval date:
07 August 2025
Amendment date:
30 June 2025
Review date:
01 July 2026
Expiry date:
31 March 2026
Type of document:
Official information for health professionals
Topic:
Respiratory syncytial virus vaccination in pregnancy
Vaccine name:
Abrysvo®
Target population:
Pregnant women
Gestational age for administration:
28–36 weeks of pregnancy
Country:
Australia
Health program:
National Immunisation Program
Availability under NIP:
From 3 February 2025
Notifiable disease status:
RSV notifiable in Victoria since 22 February 2022
Regulatory authority:
Therapeutic Goods Administration
Monitoring scheme:
Black Triangle Scheme
Related legislation:
Public Health and Wellbeing Act 2008
Intended audience:
Health professionals
Storage requirements:
+2°C to +8°C